The share of investments in research and development of new drugs made by Cipla India during fiscal year 2023 was over five percent of their overall revenue. This was a slight increase in the share allotted for research compared to the previous fiscal year. Fiscal year 2017 saw an investment of eight percent, the highest since 2014.
Share of investment in research and development at Cipla Limited from financial year 2014 to 2023
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Cipla's gross revenue FY 2015-2023
- Premium Statistic Cipla's CSR expenditure 2020 by project
- Premium Statistic Top metropolitan areas by largest employment in drugs and pharmaceuticals 2021
- Premium Statistic Life science companies in California 2019-2021, by sector
- Basic Statistic Impact of U.S. biopharmaceutical industry on employment 2020
- Basic Statistic Biopharmaceutical industry impact on labor income U.S. 2020
- Premium Statistic Cipla's dividend value FY 2009-2023
- Premium Statistic Cipla's global revenue 2023, by region
- Premium Statistic Cipla's SAGA revenue FY 2017-2018
- Basic Statistic Employment in California's life science industry in 2022, by sector
About the region
10
- Premium Statistic Cipla's profit FY 2009-2023
- Premium Statistic Cipla's API revenue FY 2017-2023
- Premium Statistic Cipla's BSE market price FY 2021-2023
- Premium Statistic Cipla's shareholders 2023, by type
- Premium Statistic Cipla's revenue share 2023, by medical therapy
- Premium Statistic Cipla's income from operations FY 2014-2023
- Premium Statistic Cipla's EBITDA margin FY 2014-2023
- Premium Statistic Cipla's number of employees 2018 by category
- Premium Statistic Cipla's global revenue share 2023, by region
- Premium Statistic GSK Pharmaceuticals' remuneration of executive directors in India 2023
Selected statistics
7
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Premium Statistic U.S. branded prescription revenue forecast 2009-2015
Other regions
10
- Premium Statistic Projection of top orphan drugs by global revenue 2028
- Basic Statistic Drug products in the pipeline in California 2020, by therapeutic area
- Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
- Premium Statistic Revenue value from biotechnology companies in Germany 2008-2022
- Premium Statistic Dedicated biotechnology company number comparison by select country 2021
- Basic Statistic European countries based on number of public biotech companies 2021
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Basic Statistic Support for research into medical use of illegal psychedelics U.S. 2017, by gender
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Consolidated net profit of the Ipsen group 2014-2019
Related statistics
10
- Premium Statistic GSK Pharmaceuticals' net profit India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' revenue share from operations in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' shareholder distribution India FY 2023
- Premium Statistic GSK Pharmaceuticals' profit before tax in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' net assets India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' EBITDA in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' India equity share capital FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' share of income utilized in India 2023, by category
- Premium Statistic GSK Pharmaceuticals' total income in India FY 2017-2023
- Premium Statistic GSK Pharmaceuticals' number of employees in India FY 2016-2023
Further related statistics
10
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Celgene's revenue and net income 2006-2018
- Medicinal market growth worldwide including rebates 2009-2018
- Net interest income of Deutsche Bank 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Net income of Dine Brands Global worldwide 2008-2023
- Operating income of Papa John's worldwide 2007-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
Further Content: You might find this interesting as well
Statistics
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Celgene's revenue and net income 2006-2018
- Medicinal market growth worldwide including rebates 2009-2018
- Net interest income of Deutsche Bank 2006-2023
- MorphoSys' research & development expenditure 2006-2023
- Net income of Dine Brands Global worldwide 2008-2023
- Operating income of Papa John's worldwide 2007-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
Cipla. (July 18, 2023). Share of investment in research and development at Cipla Limited from financial year 2014 to 2023 [Graph]. In Statista. Retrieved May 10, 2024, from https://www.statista.com/statistics/985621/india-cipla-rnd-investment-share/
Cipla. "Share of investment in research and development at Cipla Limited from financial year 2014 to 2023." Chart. July 18, 2023. Statista. Accessed May 10, 2024. https://www.statista.com/statistics/985621/india-cipla-rnd-investment-share/
Cipla. (2023). Share of investment in research and development at Cipla Limited from financial year 2014 to 2023. Statista. Statista Inc.. Accessed: May 10, 2024. https://www.statista.com/statistics/985621/india-cipla-rnd-investment-share/
Cipla. "Share of Investment in Research and Development at Cipla Limited from Financial Year 2014 to 2023." Statista, Statista Inc., 18 Jul 2023, https://www.statista.com/statistics/985621/india-cipla-rnd-investment-share/
Cipla, Share of investment in research and development at Cipla Limited from financial year 2014 to 2023 Statista, https://www.statista.com/statistics/985621/india-cipla-rnd-investment-share/ (last visited May 10, 2024)
Share of investment in research and development at Cipla Limited from financial year 2014 to 2023 [Graph], Cipla, July 18, 2023. [Online]. Available: https://www.statista.com/statistics/985621/india-cipla-rnd-investment-share/